Kemira Oyj · OMXHEX:KEMIRA
Kemira Oyj — Q2 2021 Earnings Presentation
30 slides from Kemira Oyj's earnings presentation, Jul 16, 2021
Slide 1: Strong revenue growth
JARI ROSENDAL, PRESIDENT AND CEO PETRI CASTRÉN, CFO JULY 16, 2021 Strong revenue growth JANUARY-JUNE 2021
Slide 2: Summary of Q2 2021
Summary of Q2 2021 • Very strong end-market recovery • Organic revenue growth +16% • Profitability impacted by higher raw material costs and some raw material availability issues • Actions to mitigate inflationary pressure yielding results in Q2 2021 • Growth investments in South Korea and the U.S.
Slide 3: Financial highlights of Q2 2021
Financial highlights of Q2 2021 Organic revenue growth 16% EUR million Q2 Q2 Δ% H1 H1 Δ% FY • Good demand across regions and segments (except ratios) 2021 2020 2021 2020 2020 • Organic revenue growth excl. Oil & Gas Revenue 657.5 582.9 +13% 1,263.6 1,224.9 +3% 2,427.2 business 9%. Organic growth in
Slide 4: Pulp & Paper: Continued good demand
Pulp & Paper: Continued good demand Market environment in Q2 2021 REVENUE AND ORGANIC REVENUE GROWTH (Y-ON-Y) EUR million • Pulp, board and tissue demand remained good; 381 383 386 continued stabilization in printing and writing 373 378 370 370 378 357 352 demand. Organic growth +9% +0% -3% -3% -3%
Slide 5: Industry & Water: Significant revenue recovery; profitability remained strong
Industry & Water: Significant revenue recovery; profitability remained strong Market environment in Q2 2021 REVENUE AND ORGANIC REVENUE GROWTH (Y-ON-Y) EUR million • Municipal water treatment market solid; industrial 290 307 272 279 water treatment market recovering 267 264 244 236 237 226 • Oil & G
Slide 6: Oil & Gas: Strong market recovery
Oil & Gas: Strong market recovery Market environment in Q2 2021 • Shale: market continued to recover sequentially; strong REVENUE DEVELOPMENT growth versus low comparison period EUR million • In oil sands tailings, customer treatment season began in Q2 2021. CEOR* end market expected to be solid in
Slide 7: As discussed in CMD 2020, we will increasingly focus on profitable growth going forward
As discussed in CMD 2020, we will increasingly focus on profitable growth going forward Portfolio Organic growth Continuous operational restructuring & investments and improvements with Fit for Growth focus on improving increased focus on growth fundamentals: Focus on improving relative profitabilit
Slide 8: Our path towards 500 MEUR biobased revenue advances via 4 tracks
Our path towards 500 MEUR biobased revenue advances via 4 tracks Boost the sales of commercially available CURRENT biobased products First pilot sales with PHA PORTFOLIO (partnership with Danimer) during Q2 2021 PRODUCT Convert current products to biobased through CONVERSION change of raw material a
Slide 9: Short-term growth supported by recent investments, mid-term by biobased products
Short-term growth supported by recent investments, mid-term by biobased products Completion of dry- Completion of coagulant Financial contribution of polymer capacity in expansion in the UK bleaching facility expansion South Korea in Q2 in Uruguay; facility completed by end of 2022 Completion of Cap
Slide 10: Key operative focus areas in 2021
Key operative focus areas in 2021 • Return to normality as COVID-19 situation allows; maintain high employee engagement • Continue to mitigate impacts from higher input costs • Increased focus on profitable growth; maintain focus on strict cost management • Biobased strategy: continue partnership de
Slide 11: Financials Q2 2021
PETRI CASTRÉN, CFO JULY 16, 2021 Financials Q2 2021 JULY 16, 2021 Q2 2021 RESULT PRESENTATION 11
Slide 12: Sales volumes improved strongly
Sales volumes improved strongly Q2/2021 REVENUE AND ORGANIC GROWTH (Y-ON-Y) Organic revenue growth 16% in Q2 2021 EUR million • Q2 2021 revenue increased strongly due to higher sales volumes. Also sales prices increased. 12 -21 657 658 583 83 1 • Organic revenue growth excluding Oil & Gas 9%; Oil &
Slide 13: Items affecting comparability in Q2 2021
Items affecting comparability in Q2 2021 DAMAGE CLAIM SETTLEMENT • Kemira reached a settlement with CDC on alleged old infringement of competition law in sodium chlorate business of Finnish Chemicals in 1994-2000. Kemira acquired Finnish Chemicals in 2005. • Total compensation and costs amounted to
Slide 14: Net impact from sales prices and variable costs negative
Net impact from sales prices and variable costs negative SALES PRICE VS VARIABLE COST TREND SALES PRICES AND VARIABLE COSTS (ROLLING 12-MONTH CHANGE Y-O-Y) (CHANGE Y-O-Y) EUR million EUR million 180 47 42 37 120 34 32 43 26 38 28 28 28 36 25 60 16 13 29 24 16 15 9 13 23 11 8 23 5 4 19 11 14 0 11 12
Slide 15: Cash flow
Cash flow ALL KEY FIGURES IN EUR MILLION CASH FLOW FROM OPERATIONS 386 • Cash flow from operations decreased mainly due to 375 changes in net working capital 143 146 Q4 205 210 • Net working capital increased compared to year-end Q3 71 88 121 117 due to higher inventories and receivables. NWC was 11
Slide 16: Gearing below financial target range
Gearing below financial target range DEVELOPMENT OF OPERATIVE ROCE, % 12.1% 11.6% 11.9% 11.2% 9.8% • Operative ROCE good at 11.9% driven by improvement in Pulp & Paper • Pulp & Paper operative ROCE 10.9% (Q2 2020: 9.5%) 2018* 2019 2020 Q2 2020 LTM Q2 2021 LTM • Industry & Water operative ROCE 13.6%
Slide 17: Outlook for 2021 unchanged
Outlook for 2021 unchanged ASSUMPTIONS FOR 2021 (SPECIFIED) OUTLOOK • COVID-19 pandemic continues to cause REVENUE uncertainty, but overall demand in Kemira’s end markets is recovering and expected to continue Kemira’s revenue in local currencies, excluding acquisitions to recover from 2020 in line
Slide 18: Kemira
KEMIFA 100 bemisty
Slide 19: Appendix
Appendix JULY 16, 2021 Q2 2021 RESULT PRESENTATION 19
Slide 20: Kemira in brief
Kemira in brief LAST 12 MONTHS: REVENUE EUR 2,466 MILLION, OPERATIVE EBITDA EUR 433 MILLION, OPERATIVE EBITDA MARGIN 17.6%, OPERATIVE ROCE 11.9% SEGMENT SPLIT GEOGRAPHIES PRODUCTS ◼ 40% ◼ 60% 10% ◼ 20% Other: APAC e.g. defoamers, ◼ 25% Bleaching Industry & Water Pulp & Paper 35% 1. China dispersants
Slide 21: Pulp & Paper – strong business with solid track record
Pulp & Paper – strong business with solid track record REVENUE AND OPERATIVE EBITDA REVENUE BY CUSTOMER REVENUE BY EUR million TYPE AND MARKET GROWTH PRODUCT CATEGORY 1,520 1,523 1,457 1,477 1,458 ◼ 40% ◼ 40% ◼ 20% ◼ 5% Other ◼ 40% 1,417 Pulp Board & Printing & Bleaching tissue writing papers ◼ 10%
Slide 22: Industry & Water – strong positions in chosen categories
Industry & Water – strong positions in chosen categories REVENUE AND OPERATIVE EBITDA REVENUE BY APPLICATION REVENUE BY EUR million TYPE AND MARKET GROWTH PRODUCT CATEGORY 1,136 956 1,009 1,073 970 906 ◼ 75% ◼ 15% ◼ 10% ◼ 15% ◼ 50% Water treatment Oil & Gas Other Other Coagulants 192 175 products 13
Slide 23: Currencies had a negative impact on revenue and operative EBITDA
Currencies had a negative impact on revenue and operative EBITDA KEMIRA REVENUE DISTRIBUTION H1 2021 • Main currency exposure comes via translation ◼ 8% Others impact ◼ 1% BRL ◼ 44% EUR • Transaction risk is limited as revenues and costs ◼ 2% SEK are typically in same currency due to local ◼ 2% GBP
Slide 24: Key figures
Key figures EUR million Q2 2021 Q1 2021 Q4 2020 Q3 2020 Q2 2020 2020 2019 Revenue 657.5 606.1 605.6 596.7 582.9 2,427.2 2,658.8 Operative EBITDA 107.3 104.6 107.9 113.0 105.7 435.1 410.0 margin 16.3% 17.3% 17.8% 18.9% 18.1% 17.9% 15.4% Operative EBIT 58.2 55.7 57.0 62.3 57.6 237.7 224.0 margin 8.9%
Slide 25: Cash flow
Cash flow EUR million Q2 2021 Q2 2020 2020 Net profit for the period 25 36 138 Total adjustments 74 69 298 Change in net working capital -39 -31 -3 Finance expenses -13 -7 -22 Income taxes paid -8 -6 -37 Net cash generated from operating activities 39 61 375 Purchases of subsidiaries and business ac
Slide 26: Pulp & Paper
Pulp & Paper KEY FINANCIALS EUR million Q2 2021 Q1 2021 Q4 2020 Q3 2020 Q2 2020 2020 Revenue 378.4 369.5 370.0 352.2 357.0 1,457.6 Operative EBITDA 57.8 62.9 68.9 65.5 65.6 260.2 margin 15.3% 17.0% 18.6% 18.6% 18.4% 17.9% Operative EBIT 28.1 33.2 37.5 34.8 35.7 138.0 margin 7.4% 9.0% 10.1% 9.9% 10.0
Slide 27: Industry & Water
Industry & Water KEY FINANCIALS EUR million Q2 2021 Q1 2021 Q4 2020 Q3 2020 Q2 2020 2020 Revenue 279.1 236.6 235.6 244.4 225.9 969.5 Operative EBITDA 49.5 41.7 39.0 47.6 40.0 174.8 margin 17.7% 17.6% 16.6% 19.5% 17.7% 18.0% Operative EBIT 30.1 22.5 19.5 27.5 21.9 99.7 margin 10.8% 9.5% 8.3% 11.3% 9.
Slide 28: Revenue split by country
Revenue split by country FY 2020 Other APAC 6% China 5% Other EMEA 8% USA 24% Norway 2% Netherlands 2% France 2% Italy 2% Canada 6% Russia 3% Spain 3% Brazil 2% Uruguay 2% Poland 3% Other Americas 1% UK 4% Germany 4% Finland 15% Sweden 6% JULY 16, 2021 Q2 2021 RESULT PRESENTATION 28
Slide 29: Important information about financial figures
Important information about financial figures Kemira provides certain financial performance measures (alternative performance measures) that are not defined by IFRS. Kemira believes that alternative performance measures followed by capital markets and management, such as organic growth (=revenue gro
Slide 30: Kemira
KEMIFA 100 bemisty